Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | COMMON STOCK | Options Exercise | $27.9K | +3.39K | +0.85% | $8.23 | 403K | May 21, 2021 | Direct | |
transaction | PLAB | COMMON STOCK | Sale | -$45.8K | -3.39K | -0.84% | $13.52 | 400K | May 21, 2021 | Direct | F1, F2, F3 |
transaction | PLAB | COMMON STOCK | Options Exercise | $47.2K | +5.74K | +1.44% | $8.23 | 405K | May 21, 2021 | Direct | |
transaction | PLAB | COMMON STOCK | Sale | -$77.5K | -5.74K | -1.42% | $13.51 | 400K | May 21, 2021 | Direct | F1, F2, F3 |
transaction | PLAB | COMMON STOCK | Options Exercise | $65K | +7.9K | +1.98% | $8.23 | 408K | May 24, 2021 | Direct | |
transaction | PLAB | COMMON STOCK | Sale | -$107K | -7.9K | -1.94% | $13.53 | 400K | May 24, 2021 | Direct | F1, F2, F3 |
transaction | PLAB | COMMON STOCK | Options Exercise | $230K | +28K | +7% | $8.23 | 428K | May 24, 2021 | Direct | |
transaction | PLAB | COMMON STOCK | Sale | -$379K | -28K | -6.54% | $13.53 | 400K | May 24, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -3.39K | -30.02% | $0.00 | 7.9K | May 21, 2021 | COMMON STOCK | 3.39K | $8.23 | Direct | |
transaction | PLAB | Non-Qualified Stock Options | Options Exercise | $0 | -5.74K | -17.02% | $0.00 | 28K | May 21, 2021 | COMMON STOCK | 5.74K | $8.23 | Direct | |
transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -7.9K | -100% | $0.00* | 0 | May 24, 2021 | COMMON STOCK | 7.9K | $8.23 | Direct | |
transaction | PLAB | Non-Qualified Stock Options | Options Exercise | $0 | -28K | -100% | $0.00* | 0 | May 24, 2021 | COMMON STOCK | 28K | $8.23 | Direct |
Id | Content |
---|---|
F1 | The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. |
F2 | This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
F3 | Net proceeds of sale to offset a tax liability from restricted stock vesting and to fund children's education. |